维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

7篇 您的检索式：作者名="GHARABAWI G"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Clinical improve- ment in 336 stable chronically psychoitic patients changed from oral to long-acting risperidone: a 12 month open trial 显示文摘	LASSER R BOSSIE C GHARABAWI G	2005	lnt J Neuropsycbopharmacol2005，8，3：	1
	2	Reduction in psychotic symptoms as a predictor of patient satisfaction with an- tipsychotic medication in schizophrenia: data from a randomized double-blind trial 显示文摘	Gharabawi G M Greenspan A Rupnow M F	2006	BMC Psychiatl72006，20，6：	1
	3	Effects of risperidone augmentation in patients with treatmentresistant depression: Results of open-label treatment followed by double-blind continuation 显示文摘	RAOPAPORT A GHARABAWI G M CANUSO C M	2006	Neuropsychopharmacology2006，31，11：	1
	4	Oral fispeddoneq-lorazepan ver- sus im haloperidolq-lorazepam in the emergency treatment of acute psychosis in schizophrenia and schizoaffective disorder 显示文摘	Gharabawi G Turkoz I Pandina G	2003	Inter Cong''Schizophr Res2003，18，2：	1
	5	Clinical improvement in 336 stable chronically psychotic patients changed from oral to long-acting risperidone: a 12-month open trial显示文摘	LASSER R A BOSSIE C A GHARABAWI G M	2005	Int J Neuropsychopharmacol2005，8，3：	1
	6	Effects of risperidone augmentation in patients with treatment resistant depression, results of open-label treatment followed by double blind continuation 显示文摘	RAPAPORT M H GHARABAWI G M CANUSO C M	2006	Neuropsychopharmacology2006，31，11：	1
	7	Clinical improvement in 336 stable chronically psychotic patients changed from oral to long-acting risperidone:a 12-month open trial显示文摘	LASSER R BOSSIE C GHARABAWI G	2005	Int J Neuropsychopharmacol2005，8，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费